id | C00003817 |
---|---|
Name | Apigenin / 5,7,4'-Trihydroxyflavone |
CAS RN | 520-36-5 |
Standard InChI | InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H |
Standard InChI (Main Layer) | InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H |
Phytochemical cluster | No. 15 |
---|---|
KCF-S cluster | No. 71 |
By standard InChI | CHEMBL28 |
---|---|
By standard InChI Main Layer | CHEMBL28 |
By LinkDB | C01477 |
---|
By CAS RN | D047310 |
---|
class name | count |
---|---|
asterids | 71 |
rosids | 24 |
eudicotyledons | 20 |
Liliopsida | 6 |
Euphyllophyta | 3 |
Spermatophyta | 2 |
Magnoliophyta | 1 |
family name | count |
---|---|
Lamiaceae | 37 |
Asteraceae | 24 |
Berberidaceae | 18 |
Fabaceae | 6 |
Plantaginaceae | 3 |
Pteridaceae | 3 |
Thymelaeaceae | 2 |
Zygophyllaceae | 2 |
Xanthorrhoeaceae | 2 |
Moraceae | 2 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL28 |
CHEMBL1614110
(2)
CHEMBL1741321
(2)
|
1 / 0 |
Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 | Ste7 | CHEMBL28 |
CHEMBL1063679
(1)
|
1 / 1 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | CHEMBL28 |
CHEMBL957998
(1)
CHEMBL957999
(1)
|
0 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | CHEMBL28 |
CHEMBL1062294
(1)
CHEMBL2076527
(1)
|
0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | CHEMBL28 |
CHEMBL1908081
(1)
CHEMBL1908082
(1)
|
3 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL28 |
CHEMBL1613992
(2)
CHEMBL1613995
(1)
CHEMBL2114895 (2) |
7 / 44 |
Q9NPH5 | NADPH oxidase 4 | Enzyme | CHEMBL28 |
CHEMBL1249157
(1)
CHEMBL1249158
(1)
CHEMBL1249160 (1) |
0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL28 |
CHEMBL1613842
(5)
|
4 / 2 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | CHEMBL28 |
CHEMBL1908087
(1)
|
0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL28 |
CHEMBL1794367
(1)
CHEMBL2114784
(1)
|
1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL28 |
CHEMBL1794499
(1)
|
2 / 0 |
P14618 | Pyruvate kinase PKM | Enzyme | CHEMBL28 |
CHEMBL1614177
(1)
CHEMBL1614265
(1)
|
0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | CHEMBL28 |
CHEMBL1071606
(1)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL28 |
CHEMBL1008495
(2)
CHEMBL1008498
(1)
|
0 / 3 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL28 |
CHEMBL636747
(1)
CHEMBL643650
(1)
|
0 / 0 |
Q15759 | Mitogen-activated protein kinase 11 | p38 | CHEMBL28 |
CHEMBL1061119
(1)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL28 |
CHEMBL1063691
(1)
|
0 / 0 |
O15530 | 3-phosphoinositide-dependent protein kinase 1 | Pdk1 | CHEMBL28 |
CHEMBL1052131
(1)
|
0 / 0 |
P04062 | Glucosylceramidase | Enzyme | CHEMBL28 |
CHEMBL1613818
(5)
|
6 / 4 |
P41240 | Tyrosine-protein kinase CSK | Csk | CHEMBL28 |
CHEMBL1061124
(1)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL28 |
CHEMBL1063681
(1)
|
0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | CHEMBL28 |
CHEMBL1794524
(2)
CHEMBL1794552
(1)
CHEMBL2341203 (1) CHEMBL2341207 (1) |
0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL28 |
CHEMBL1738600
(1)
CHEMBL1794585
(1)
|
0 / 0 |
O14757 | Serine/threonine-protein kinase Chk1 | Chk1 | CHEMBL28 |
CHEMBL1051273
(1)
|
0 / 0 |
O95271 | Tankyrase-1 | Enzyme | CHEMBL28 |
CHEMBL2341188
(2)
|
0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | CHEMBL28 |
CHEMBL1614331
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL28 |
CHEMBL1614310
(1)
CHEMBL1614544
(2)
|
11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL28 |
CHEMBL1614361
(1)
|
3 / 2 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | CHEMBL28 |
CHEMBL1023248
(1)
|
1 / 1 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL28 |
CHEMBL1614554
(1)
CHEMBL1613776
(1)
|
3 / 1 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | CHEMBL28 |
CHEMBL1794371
(2)
CHEMBL1794471
(2)
|
0 / 0 |
P68400 | Casein kinase II subunit alpha | Ck2 | CHEMBL28 |
CHEMBL974405
(1)
CHEMBL1062826
(1)
CHEMBL1061117 (1) |
0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL28 |
CHEMBL1071605
(1)
|
1 / 1 |
Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | CHEMBL28 |
CHEMBL832923
(1)
|
1 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | CHEMBL28 |
CHEMBL862675
(1)
CHEMBL862676
(1)
CHEMBL926333 (1) |
0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | CHEMBL28 |
CHEMBL1225717
(1)
CHEMBL1780345
(1)
|
0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL28 |
CHEMBL1827948
(1)
|
1 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | CHEMBL28 |
CHEMBL1063693
(1)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL28 |
CHEMBL1614027
(2)
CHEMBL1741325
(2)
|
0 / 1 |
P23443 | Ribosomal protein S6 kinase beta-1 | p70 | CHEMBL28 |
CHEMBL1060172
(1)
|
0 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | CHEMBL28 |
CHEMBL876996
(1)
|
0 / 0 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | CHEMBL28 |
CHEMBL876996
(1)
|
0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL28 |
CHEMBL941404
(1)
|
1 / 11 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | CHEMBL28 |
CHEMBL1014685
(1)
CHEMBL1014691
(1)
CHEMBL1014692 (1) CHEMBL1014693 (1) |
0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL28 |
CHEMBL1794376
(1)
|
2 / 3 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL28 |
CHEMBL1008497
(1)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL28 |
CHEMBL926465
(1)
CHEMBL926470
(1)
|
0 / 0 |
O75582 | Ribosomal protein S6 kinase alpha-5 | CAMK serine/threonine protein kinase MSKB subfamily | CHEMBL28 |
CHEMBL1063680
(1)
|
0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | CHEMBL28 |
CHEMBL1100507
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL28 |
CHEMBL1614458
(6)
|
0 / 0 |
P68871 | Hemoglobin subunit beta | Secreted protein | CHEMBL28 |
CHEMBL1613976
(1)
|
4 / 4 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | CHEMBL28 |
CHEMBL2342404
(1)
|
1 / 1 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL28 |
CHEMBL1614456
(2)
CHEMBL1613803
(2)
|
0 / 0 |
P09769 | Tyrosine-protein kinase Fgr | Src | CHEMBL28 |
CHEMBL1051346
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL28 |
CHEMBL1794486
(1)
|
0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL28 |
CHEMBL1794584
(1)
|
2 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL28 |
CHEMBL1613941
(1)
|
0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | CHEMBL28 |
CHEMBL2114807
(1)
|
4 / 2 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | CHEMBL28 |
CHEMBL1908090
(1)
|
0 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL28 |
CHEMBL926467
(1)
CHEMBL926472
(1)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL28 |
CHEMBL679353
(1)
CHEMBL876871
(1)
CHEMBL678095 (1) |
0 / 1 |
P10145 | Interleukin-8 | Secreted protein | CHEMBL28 |
CHEMBL2114835
(1)
|
0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | CHEMBL28 |
CHEMBL832706
(1)
CHEMBL1063786
(1)
|
0 / 0 |
Q15418 | Ribosomal protein S6 kinase alpha-1 | Rskb | CHEMBL28 |
CHEMBL1061120
(1)
|
0 / 0 |
O15264 | Mitogen-activated protein kinase 13 | p38 | CHEMBL28 |
CHEMBL1060170
(1)
|
0 / 0 |
P09874 | Poly [ADP-ribose] polymerase 1 | Enzyme | CHEMBL28 |
CHEMBL2341185
(1)
|
0 / 0 |
Q12791 | Calcium-activated potassium channel subunit alpha-1 | KCNM, KCa1.x | CHEMBL28 |
CHEMBL767233
(1)
|
1 / 1 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL28 |
CHEMBL1794569
(1)
|
1 / 1 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | CHEMBL28 |
CHEMBL1963893
(1)
|
0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL28 |
CHEMBL1794467
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL28 |
CHEMBL1052488
(1)
CHEMBL1052489
(1)
CHEMBL1794382 (2) CHEMBL1794456 (2) |
0 / 1 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | CHEMBL28 |
CHEMBL978974
(1)
CHEMBL987971
(1)
CHEMBL1105634 (1) |
2 / 2 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL28 |
CHEMBL1059360
(1)
CHEMBL1059361
(1)
CHEMBL1062054 (1) CHEMBL1794293 (1) CHEMBL1794510 (1) |
5 / 3 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | CHEMBL28 |
CHEMBL1225718
(1)
CHEMBL1780346
(1)
|
4 / 4 |
P06276 | Cholinesterase | Hydrolase | CHEMBL28 |
CHEMBL1045780
(1)
CHEMBL2020733
(1)
|
0 / 0 |
P49137 | MAP kinase-activated protein kinase 2 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL28 |
CHEMBL1062862
(1)
|
0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | CHEMBL28 |
CHEMBL1794437
(2)
|
0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL28 |
CHEMBL1052129
(1)
CHEMBL1613808
(1)
|
0 / 0 |
P56817 | Beta-secretase 1 | A1A | CHEMBL28 |
CHEMBL2020741
(1)
CHEMBL2020742
(1)
|
0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL28 |
CHEMBL1225716
(1)
CHEMBL1741322
(2)
|
0 / 0 |
Q9Y4K4 | Mitogen-activated protein kinase kinase kinase kinase 5 | STE serine/threonine protein kinase KHS subfamily | CHEMBL28 |
CHEMBL1061122
(1)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL28 |
CHEMBL1613910
(1)
CHEMBL1614227
(2)
|
3 / 3 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | CHEMBL28 |
CHEMBL1687393
(1)
CHEMBL1687394
(1)
CHEMBL2076243 (1) CHEMBL2076830 (1) CHEMBL2076844 (1) |
2 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | CHEMBL28 |
CHEMBL1006005
(1)
|
1 / 1 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL28 |
CHEMBL1614038
(4)
|
2 / 2 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | CHEMBL28 |
CHEMBL1614342
(1)
|
1 / 1 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | CHEMBL28 |
CHEMBL1614171
(1)
|
5 / 2 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | CHEMBL28 |
CHEMBL2114842
(1)
|
0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL28 |
CHEMBL1738675
(1)
CHEMBL1737868
(1)
|
0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | CHEMBL28 |
CHEMBL1908085
(2)
|
0 / 0 |
Q9H2K2 | Tankyrase-2 | Enzyme | CHEMBL28 |
CHEMBL2341186
(2)
|
0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL28 |
CHEMBL998835
(1)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL28 |
CHEMBL679353
(1)
CHEMBL679323
(1)
CHEMBL1794364 (2) CHEMBL1794542 (2) |
1 / 1 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL28 |
CHEMBL1045781
(1)
CHEMBL2020732
(1)
|
1 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL28 |
CHEMBL926466
(1)
CHEMBL926471
(1)
|
0 / 0 |
Q8IW41 | MAP kinase-activated protein kinase 5 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL28 |
CHEMBL1061121
(1)
|
0 / 0 |
O75116 | Rho-associated protein kinase 2 | Rock | CHEMBL28 |
CHEMBL1062037
(1)
|
0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL28 |
CHEMBL1614274
(1)
CHEMBL1613823
(1)
|
0 / 0 |
P07948 | Tyrosine-protein kinase Lyn | Src | CHEMBL28 |
CHEMBL1051275
(1)
|
0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | CHEMBL28 |
CHEMBL687375
(1)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL28 |
CHEMBL1614240
(1)
|
0 / 0 |
P31749 | RAC-alpha serine/threonine-protein kinase | Akt | CHEMBL28 |
CHEMBL1061152
(1)
|
4 / 1 |
O00141 | Serine/threonine-protein kinase Sgk1 | AGC serine/threonine protein kinase SGK subfamily | CHEMBL28 |
CHEMBL1060171
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL28 |
CHEMBL1613777
(2)
CHEMBL1741323
(2)
|
1 / 1 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | CHEMBL28 |
CHEMBL958788
(1)
CHEMBL958789
(1)
|
0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL28 |
CHEMBL1614108
(3)
CHEMBL1613886
(3)
CHEMBL1741324 (2) |
0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL28 |
CHEMBL1794483
(1)
|
0 / 0 |
Q15046 | Lysine--tRNA ligase | Enzyme | CHEMBL28 |
CHEMBL2173401
(1)
CHEMBL2173408
(1)
|
2 / 1 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | CHEMBL28 |
CHEMBL1614052
(1)
|
1 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL28 |
CHEMBL1614283
(1)
CHEMBL1614211
(2)
|
0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | CHEMBL28 |
CHEMBL1908080
(1)
|
5 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL28 |
CHEMBL1614250
(1)
CHEMBL1614421
(5)
CHEMBL1614502 (2) |
4 / 3 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | CHEMBL28 |
CHEMBL1738402
(1)
|
0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL28 |
CHEMBL1738184
(1)
CHEMBL2114890
(2)
|
0 / 0 |
P10275 | Androgen receptor | NR3C4 | CHEMBL28 |
CHEMBL1052486
(1)
CHEMBL1052490
(1)
CHEMBL1794321 (2) CHEMBL1794560 (2) |
3 / 4 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | CHEMBL28 |
CHEMBL1059364
(1)
CHEMBL1059365
(1)
|
0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL28 |
CHEMBL941407
(1)
CHEMBL1061123
(1)
|
0 / 1 |
P54646 | 5'-AMP-activated protein kinase catalytic subunit alpha-2 | Ampk | CHEMBL28 |
CHEMBL1063692
(1)
|
0 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | CHEMBL28 |
CHEMBL2114849
(2)
|
0 / 0 |
P43405 | Tyrosine-protein kinase SYK | Syk | CHEMBL28 |
CHEMBL1063695
(1)
|
0 / 0 |
Q13627 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | CMGC dual-specificity kinase DYRK1 | CHEMBL28 |
CHEMBL1060231
(1)
|
1 / 0 |
P53778 | Mitogen-activated protein kinase 12 | p38 | CHEMBL28 |
CHEMBL1060169
(1)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL28 |
CHEMBL1794536
(1)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL28 |
CHEMBL1613914
(1)
|
0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | CHEMBL28 |
CHEMBL1614086
(1)
CHEMBL1614034
(1)
|
1 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL28 |
CHEMBL1614364
(4)
|
1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL28 |
CHEMBL2354311
(1)
|
1 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL28 |
CHEMBL1614257
(5)
CHEMBL1614531
(2)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL28 |
CHEMBL1614257
(5)
CHEMBL1614531
(2)
|
1 / 3 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL28 |
CHEMBL1613933
(2)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL28 |
CHEMBL1613933
(2)
|
1 / 6 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | CHEMBL28 |
CHEMBL877825
(1)
|
0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | CHEMBL28 |
CHEMBL877825
(1)
|
1 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | CHEMBL28 |
CHEMBL877825
(1)
|
1 / 1 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | CHEMBL28 |
CHEMBL877825
(1)
|
0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | CHEMBL28 |
CHEMBL877825
(1)
|
1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | CHEMBL28 |
CHEMBL877825
(1)
|
0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | CHEMBL28 |
CHEMBL877825
(1)
|
0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | CHEMBL28 |
CHEMBL877825
(1)
|
0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | CHEMBL28 |
CHEMBL877825
(1)
|
0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | CHEMBL28 |
CHEMBL877825
(1)
|
0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | CHEMBL28 |
CHEMBL877825
(1)
|
0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | CHEMBL28 |
CHEMBL877825
(1)
|
0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | CHEMBL28 |
CHEMBL877825
(1)
|
4 / 2 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | CHEMBL28 |
CHEMBL877825
(1)
|
0 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | CHEMBL28 |
CHEMBL877825
(1)
|
0 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | CHEMBL28 |
CHEMBL877825
(1)
|
1 / 0 |
P45983 | Mitogen-activated protein kinase 8 | Jnk | CHEMBL28 |
CHEMBL1061151
(1)
|
0 / 0 |
P53779 | Mitogen-activated protein kinase 10 | Jnk | CHEMBL28 |
CHEMBL1061151
(1)
|
0 / 1 |
P45984 | Mitogen-activated protein kinase 9 | Jnk | CHEMBL28 |
CHEMBL1061151
(1)
|
0 / 0 |
O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | CHEMBL28 |
CHEMBL832848
(1)
|
0 / 0 |
P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | CHEMBL28 |
CHEMBL832848
(1)
|
0 / 0 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | CHEMBL28 |
CHEMBL832848
(1)
|
0 / 0 |
Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | CHEMBL28 |
CHEMBL832848
(1)
|
0 / 0 |
P22694 | cAMP-dependent protein kinase catalytic subunit beta | Pka | CHEMBL28 |
CHEMBL1052130
(1)
|
0 / 0 |
P17612 | cAMP-dependent protein kinase catalytic subunit alpha | Pka | CHEMBL28 |
CHEMBL1052130
(1)
|
0 / 0 |
P22612 | cAMP-dependent protein kinase catalytic subunit gamma | Pka | CHEMBL28 |
CHEMBL1052130
(1)
|
0 / 0 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | CHEMBL28 |
CHEMBL832706
(1)
|
0 / 0 |
Q9HCP0 | Casein kinase I isoform gamma-1 | Ck1 | CHEMBL28 |
CHEMBL1051274
(1)
|
0 / 0 |
P48730 | Casein kinase I isoform delta | Ck1 | CHEMBL28 |
CHEMBL1051274
(1)
|
1 / 0 |
P49674 | Casein kinase I isoform epsilon | Ck1 | CHEMBL28 |
CHEMBL1051274
(1)
|
0 / 0 |
P78368 | Casein kinase I isoform gamma-2 | Ck1 | CHEMBL28 |
CHEMBL1051274
(1)
|
0 / 0 |
P48729 | Casein kinase I isoform alpha | Ck1 | CHEMBL28 |
CHEMBL1051274
(1)
|
0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | CHEMBL28 |
CHEMBL2114738
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D047310 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | Apigenin results in decreased activity of ABCC1 protein |
decreases activity
|
protein |
15670588
|
D047310 | 196 |
AHR
bHLHe76 |
aryl hydrocarbon receptor | Apigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of AHR protein] |
decreases reaction
/ increases phosphorylation |
protein |
20450880
|
D047310 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | [Apigenin co-treated with Fluorouracil] results in decreased expression of AKT1 protein |
affects cotreatment
/ decreases expression |
protein |
19885610
|
D047310 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | Apigenin results in decreased expression of AKT1 protein |
decreases expression
|
protein |
15947208
|
D047310 | 405 |
ARNT
HIF-1-beta HIF-1beta HIF1-beta HIF1B HIF1BETA TANGO bHLHe2 |
aryl hydrocarbon receptor nuclear translocator | Apigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of ARNT protein] |
decreases reaction
/ increases phosphorylation |
protein |
20450880
|
D047310 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | Apigenin results in decreased expression of BCL2 protein |
decreases expression
|
protein |
15486995
|
D047310 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | BCL2 protein results in decreased susceptibility to Apigenin |
decreases response to substance
|
protein |
15486995
|
D047310 | 330 |
BIRC3
AIP1 API2 CIAP2 HAIP1 HIAP1 MALT2 MIHC RNF49 c-IAP2 |
baculoviral IAP repeat containing 3 | Apigenin results in increased cleavage of BIRC3 protein |
increases cleavage
|
protein |
15486995
|
D047310 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP3 protein] |
increases activity
/ increases reaction |
protein |
19885610
|
D047310 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Apigenin results in increased activity of CASP3 protein |
increases activity
|
protein |
17132221
19647729 |
D047310 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Apigenin results in increased cleavage of CASP3 protein |
increases cleavage
|
protein |
15486995
19397994 |
D047310 | 840 |
CASP7
CASP-7 CMH-1 ICE-LAP3 LICE2 MCH3 |
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) | Apigenin results in increased activity of CASP7 protein |
increases activity
|
protein |
19647729
|
D047310 | 840 |
CASP7
CASP-7 CMH-1 ICE-LAP3 LICE2 MCH3 |
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) | Apigenin results in increased cleavage of CASP7 protein |
increases cleavage
|
protein |
15486995
|
D047310 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | Apigenin results in increased cleavage of CASP8 protein |
increases cleavage
|
protein |
15486995
|
D047310 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | Apigenin results in increased cleavage of CASP9 protein |
increases cleavage
|
protein |
15486995
19397994 |
D047310 | 847 |
CAT
|
catalase (EC:1.11.1.6) | Apigenin results in decreased expression of CAT mRNA |
decreases expression
|
mRNA |
21756884
|
D047310 | 847 |
CAT
|
catalase (EC:1.11.1.6) | CAT protein results in decreased susceptibility to Apigenin |
decreases response to substance
|
protein |
21756884
|
D047310 | 891 |
CCNB1
CCNB |
cyclin B1 | Apigenin results in decreased expression of CCNB1 mRNA |
decreases expression
|
mRNA |
19397994
|
D047310 | 891 |
CCNB1
CCNB |
cyclin B1 | Apigenin results in decreased expression of CCNB1 protein |
decreases expression
|
protein |
19397994
|
D047310 | 958 |
CD40
Bp50 CDW40 TNFRSF5 p50 |
CD40 molecule, TNF receptor superfamily member 5 | Apigenin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein] |
affects cotreatment
/ decreases reaction / increases expression |
protein |
16601352
|
D047310 | 983 |
CDK1
CDC2 CDC28A P34CDC2 |
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) | Apigenin results in increased phosphorylation of and results in decreased activity of CDK1 protein |
decreases activity
/ increases phosphorylation |
protein |
11322924
|
D047310 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | Apigenin results in increased expression of CDKN1A mRNA |
increases expression
|
mRNA |
19397994
|
D047310 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | Apigenin results in increased expression of CDKN1A protein |
increases expression
|
protein |
11790449
16023288 19397994 |
D047310 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | TP53 protein affects the reaction [Apigenin results in increased expression of CDKN1A protein] |
affects reaction
/ increases expression |
protein |
11790449
|
D047310 | 1031 |
CDKN2C
INK4C p18 p18-INK4C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | Apigenin results in increased expression of CDKN2C mRNA |
increases expression
|
mRNA |
18331776
|
D047310 | 1080 |
CFTR
ABC35 ABCC7 CF CFTR/MRP MRP7 TNR-CFTR dJ760C5.1 |
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) | Apigenin affects the localization of CFTR protein mutant form |
affects localization
|
protein |
15191910
|
D047310 | 1080 |
CFTR
ABC35 ABCC7 CF CFTR/MRP MRP7 TNR-CFTR dJ760C5.1 |
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) | Apigenin results in increased activity of CFTR protein |
increases activity
|
protein |
15277574
|
D047310 | 1080 |
CFTR
ABC35 ABCC7 CF CFTR/MRP MRP7 TNR-CFTR dJ760C5.1 |
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) | Apigenin results in increased activity of CFTR protein mutant form |
increases activity
|
protein |
15191910
|
D047310 | 6387 |
CXCL12
IRH PBSF SCYB12 SDF1 TLSF TPAR1 SDF1A SDF1B |
chemokine (C-X-C motif) ligand 12 | Apigenin results in increased expression of CXCL12 mRNA |
increases expression
|
mRNA |
23384675
|
D047310 | 6387 |
CXCL12
IRH PBSF SCYB12 SDF1 TLSF TPAR1 SDF1A SDF1B |
chemokine (C-X-C motif) ligand 12 | ESR1 protein inhibits the reaction [Apigenin results in increased expression of CXCL12 mRNA] |
decreases reaction
/ increases expression |
mRNA |
23384675
|
D047310 | 54205 |
CYCS
CYC HCS THC4 |
cytochrome c, somatic | Apigenin affects the localization of CYCS protein |
affects localization
|
protein |
15486995
|
D047310 | 1584 |
CYP11B1
CPN1 CYP11B FHI P450C11 |
cytochrome P450, family 11, subfamily B, polypeptide 1 (EC:1.14.15.4) | Apigenin results in decreased expression of CYP11B1 mRNA |
decreases expression
|
mRNA |
22172629
|
D047310 | 1586 |
CYP17A1
CPT7 CYP17 P450C17 S17AH |
cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) | Apigenin inhibits the reaction [Colforsin results in increased expression of CYP17A1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
23370353
|
D047310 | 1588 |
CYP19A1
ARO ARO1 CPV1 CYAR CYP19 CYPXIX P-450AROM |
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | Apigenin results in decreased activity of CYP19A1 protein |
decreases activity
|
protein |
10403137
15319488 16023337 16965912 |
D047310 | 1588 |
CYP19A1
ARO ARO1 CPV1 CYAR CYP19 CYPXIX P-450AROM |
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | Apigenin results in decreased expression of CYP19A1 mRNA |
decreases expression
|
mRNA |
16965912
|
D047310 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Apigenin binds to and results in decreased activity of CYP1A1 protein |
affects binding
/ decreases activity |
protein |
11454723
|
D047310 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Apigenin inhibits the reaction [CYP1A1 results in increased activity of Benzo(a)pyrene] |
decreases reaction
/ increases activity |
11752233
|
|
D047310 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Apigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
11454723
17012224 17090139 |
D047310 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Apigenin results in decreased activity of CYP1A1 protein |
decreases activity
|
protein |
16271822
21053930 21482471 |
D047310 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Apigenin results in increased expression of CYP1A1 mRNA |
increases expression
|
mRNA |
11454723
|
D047310 | 1544 |
CYP1A2
CP12 P3-450 P450(PA) |
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | Apigenin results in decreased activity of CYP1A2 protein |
decreases activity
|
protein |
20806393
21053930 |
D047310 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | Apigenin binds to and results in decreased activity of CYP1B1 protein |
affects binding
/ decreases activity |
protein |
21053930
|
D047310 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | Apigenin results in decreased activity of CYP1B1 protein |
decreases activity
|
protein |
16271822
21482471 |
D047310 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | CYP1B1 protein results in increased chemical synthesis of Apigenin |
increases chemical synthesis
|
protein |
19666078
|
D047310 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | [CYP1B1 protein results in increased metabolism of genkwanin] which results in increased chemical synthesis of Apigenin |
increases chemical synthesis
/ increases metabolic processing |
protein |
19666078
|
D047310 | 1589 |
CYP21A2
CA21H CAH1 CPS1 CYP21 CYP21B P450c21B |
cytochrome P450, family 21, subfamily A, polypeptide 2 (EC:1.14.99.10) | Apigenin inhibits the reaction [Colforsin results in increased expression of CYP21A2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
23370353
|
D047310 | 1559 |
CYP2C9
CPC9 CYP2C CYP2C10 CYPIIC9 P450IIC9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | Apigenin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] |
decreases reaction
/ increases hydroxylation |
protein |
21053930
|
D047310 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | Apigenin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam] |
decreases reaction
/ increases chemical synthesis / increases oxidation |
protein |
21053930
|
D047310 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | Apigenin promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam] |
increases chemical synthesis
/ increases oxidation / increases reaction |
protein |
21053930
|
D047310 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | Apigenin results in decreased activity of CYP3A4 protein |
decreases activity
|
protein |
21053930
|
D047310 | 2064 |
ERBB2
CD340 HER-2 HER-2/neu HER2 MLN_19 NEU NGL TKR1 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) | [Apigenin co-treated with Fluorouracil] results in decreased expression of ERBB2 protein |
affects cotreatment
/ decreases expression |
protein |
19885610
|
D047310 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Apigenin binds to and results in increased activity of ESR1 protein |
affects binding
/ increases activity |
protein |
16541309
|
D047310 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Apigenin binds to ESR1 protein |
affects binding
|
protein |
14579009
|
D047310 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Apigenin inhibits the reaction [Estradiol binds to ESR1 protein] |
affects binding
/ decreases reaction |
protein |
14579009
|
D047310 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Apigenin results in decreased expression of ESR1 protein |
decreases expression
|
protein |
16541309
|
D047310 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Apigenin results in increased activity of ESR1 protein |
increases activity
|
protein |
16118406
16860978 |
D047310 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | ESR1 protein inhibits the reaction [Apigenin results in increased expression of CXCL12 mRNA] |
decreases reaction
/ increases expression |
protein |
23384675
|
D047310 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | ESR1 protein inhibits the reaction [Apigenin results in increased expression of WISP2 mRNA] |
decreases reaction
/ increases expression |
protein |
23384675
|
D047310 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | Apigenin binds to and results in increased activity of ESR2 protein |
affects binding
/ increases activity |
protein |
9751507
|
D047310 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | Apigenin binds to ESR2 protein |
affects binding
|
protein |
12224631
|
D047310 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | Apigenin inhibits the reaction [Estradiol binds to ESR2 protein] |
affects binding
/ decreases reaction |
protein |
9751507
|
D047310 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | Apigenin results in increased activity of ESR2 protein |
increases activity
|
protein |
16118406
16860978 17132221 |
D047310 | 2203 |
FBP1
FBP |
fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) | Apigenin results in decreased expression of FBP1 mRNA |
decreases expression
|
mRNA |
18331776
|
D047310 | 2353 |
FOS
AP-1 C-FOS p55 |
FBJ murine osteosarcoma viral oncogene homolog | Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of FOS protein] |
decreases reaction
/ increases activity / increases expression |
protein |
22634262
|
D047310 | 2353 |
FOS
AP-1 C-FOS p55 |
FBJ murine osteosarcoma viral oncogene homolog | Apigenin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]] |
affects binding
/ decreases reaction / increases activity |
protein |
15322261
|
D047310 | 2353 |
FOS
AP-1 C-FOS p55 |
FBJ murine osteosarcoma viral oncogene homolog | Apigenin inhibits the reaction [TNF protein results in increased expression of FOS mRNA] |
decreases reaction
/ increases expression |
mRNA |
15322261
|
D047310 | 2729 |
GCLC
GCL GCS GLCL GLCLC |
glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) | Apigenin results in increased expression of GCLC mRNA |
increases expression
|
mRNA |
11864778
|
D047310 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Apigenin results in decreased expression of HIF1A protein |
decreases expression
|
protein |
15947208
|
D047310 | 3284 |
HSD3B2
HSD3B HSDB SDR11E2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (EC:1.1.1.145 5.3.3.1) | Apigenin inhibits the reaction [Colforsin results in increased expression of HSD3B2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
23370353
|
D047310 | 3383 |
ICAM1
BB2 CD54 P3.58 |
intercellular adhesion molecule 1 | Apigenin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
15113938
15322261 |
D047310 | 3383 |
ICAM1
BB2 CD54 P3.58 |
intercellular adhesion molecule 1 | Apigenin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
decreases reaction
/ increases expression |
protein |
15113938
15322261 |
D047310 | 3565 |
IL4
BCGF-1 BCGF1 BSF-1 BSF1 IL-4 |
interleukin 4 | Apigenin results in decreased expression of IL4 protein |
decreases expression
|
protein |
16343431
|
D047310 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | Apigenin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]] |
affects binding
/ decreases reaction / increases activity |
protein |
15322261
|
D047310 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | Apigenin inhibits the reaction [TNF protein results in increased expression of JUN mRNA] |
decreases reaction
/ increases expression |
mRNA |
15322261
|
D047310 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [[Apigenin results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
decreases reaction
/ increases abundance / increases activity / increases phosphorylation |
protein |
19647729
|
D047310 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Apigenin inhibits the reaction [TNF protein results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity |
protein |
15322261
|
D047310 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | [Apigenin results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK1 protein |
increases abundance
/ increases activity / increases phosphorylation |
protein |
19647729
|
D047310 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Apigenin results in increased phosphorylation of and results in increased activity of MAPK1 protein |
increases activity
/ increases phosphorylation |
protein |
19647729
|
D047310 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [[Apigenin results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
decreases reaction
/ increases abundance / increases activity / increases phosphorylation |
protein |
19647729
|
D047310 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | [Apigenin results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK3 protein |
increases abundance
/ increases activity / increases phosphorylation |
protein |
19647729
|
D047310 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Apigenin results in increased phosphorylation of and results in increased activity of MAPK3 protein |
increases activity
/ increases phosphorylation |
protein |
19647729
|
D047310 | 4312 |
MMP1
CLG CLGN |
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) | Apigenin results in decreased expression of MMP1 mRNA |
decreases expression
|
mRNA |
21112745
|
D047310 | 4312 |
MMP1
CLG CLGN |
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) | Apigenin results in decreased expression of MMP1 protein |
decreases expression
|
protein |
21112745
|
D047310 | 4318 |
MMP9
CLG4B GELB MANDP2 MMP-9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) | Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] |
decreases reaction
/ increases activity |
protein |
22634262
|
D047310 | 4318 |
MMP9
CLG4B GELB MANDP2 MMP-9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) | Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] |
decreases reaction
/ increases expression |
mRNA |
22634262
|
D047310 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Apigenin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein] |
decreases reaction
/ increases degradation |
protein |
15322261
|
D047310 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Apigenin inhibits the reaction [TNF protein results in increased phosphorylation of [NFKBIB protein binds to NFKBIA protein]] |
affects binding
/ decreases reaction / increases phosphorylation |
protein |
15322261
|
D047310 | 4793 |
NFKBIB
IKBB TRIP9 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | Apigenin inhibits the reaction [TNF protein results in increased phosphorylation of [NFKBIB protein binds to NFKBIA protein]] |
affects binding
/ decreases reaction / increases phosphorylation |
protein |
15322261
|
D047310 | 5241 |
PGR
NR3C3 PR |
progesterone receptor | Apigenin binds to PGR protein |
affects binding
|
protein |
14579009
|
D047310 | 5241 |
PGR
NR3C3 PR |
progesterone receptor | Apigenin inhibits the reaction [Progesterone binds to PGR protein] |
affects binding
/ decreases reaction |
protein |
14579009
|
D047310 | 5562 |
PRKAA1
AMPK AMPKa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) | Apigenin inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] |
decreases activity
/ decreases phosphorylation / decreases reaction |
protein |
16873680
|
D047310 | 8000 |
PSCA
PRO232 |
prostate stem cell antigen | Apigenin results in decreased expression of PSCA mRNA |
decreases expression
|
mRNA |
18331776
|
D047310 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of RELA protein] |
decreases reaction
/ increases activity / increases expression |
protein |
22634262
|
D047310 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Apigenin inhibits the reaction [TNF protein affects the localization of RELA protein] |
affects localization
/ decreases reaction |
protein |
15113938
|
D047310 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Apigenin results in increased expression of RELA protein |
increases expression
|
protein |
15090468
|
D047310 | 6198 |
RPS6KB1
PS6K S6K S6K-beta-1 S6K1 STK14A p70_S6KA p70(S6K)-alpha p70-S6K p70-alpha |
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) | Apigenin results in decreased expression of RPS6KB1 protein |
decreases expression
|
protein |
15947208
|
D047310 | 6401 |
SELE
CD62E ELAM ELAM1 ESEL LECAM2 |
selectin E | Apigenin inhibits the reaction [TNF protein results in increased expression of SELE mRNA] |
decreases reaction
/ increases expression |
mRNA |
15113938
|
D047310 | 6401 |
SELE
CD62E ELAM ELAM1 ESEL LECAM2 |
selectin E | Apigenin inhibits the reaction [TNF protein results in increased expression of SELE protein] |
decreases reaction
/ increases expression |
protein |
15113938
|
D047310 | 6817 |
SULT1A1
HAST1/HAST2 P-PST PST ST1A1 ST1A3 STP STP1 TSPST1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) | SULT1A1 protein SNP results in increased sulfation of Apigenin |
increases sulfation
|
protein |
17293380
|
D047310 | 6783 |
SULT1E1
EST EST-1 ST1E1 STE |
sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) | Apigenin inhibits the reaction [Progesterone results in increased expression of SULT1E1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
22414680
|
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein affects the localization of RELA protein] |
affects localization
/ decreases reaction |
protein |
15113938
|
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]] |
affects binding
/ decreases reaction / increases activity |
protein |
15322261
|
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity |
protein |
15322261
|
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein] |
decreases reaction
/ increases degradation |
protein |
15322261
|
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein results in increased expression of FOS mRNA] |
decreases reaction
/ increases expression |
protein |
15322261
|
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] |
decreases reaction
/ increases expression |
protein |
15113938
15322261 |
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
decreases reaction
/ increases expression |
protein |
15113938
15322261 |
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein results in increased expression of JUN mRNA] |
decreases reaction
/ increases expression |
protein |
15322261
|
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein results in increased expression of SELE mRNA] |
decreases reaction
/ increases expression |
protein |
15113938
|
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein results in increased expression of SELE protein] |
decreases reaction
/ increases expression |
protein |
15113938
|
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA] |
decreases reaction
/ increases expression |
protein |
15113938
|
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
decreases reaction
/ increases expression |
protein |
15113938
|
D047310 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Apigenin inhibits the reaction [TNF protein results in increased phosphorylation of [NFKBIB protein binds to NFKBIA protein]] |
affects binding
/ decreases reaction / increases phosphorylation |
protein |
15322261
|
D047310 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | Apigenin results in increased expression of TP53 protein |
increases expression
|
protein |
16023288
|
D047310 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | TP53 protein affects the reaction [Apigenin results in increased expression of CDKN1A protein] |
affects reaction
/ increases expression |
protein |
11790449
|
D047310 | 9540 |
TP53I3
PIG3 |
tumor protein p53 inducible protein 3 | Apigenin results in increased expression of TP53I3 mRNA |
increases expression
|
mRNA |
19397994
|
D047310 | 9540 |
TP53I3
PIG3 |
tumor protein p53 inducible protein 3 | Apigenin results in increased expression of TP53I3 protein |
increases expression
|
protein |
19397994
|
D047310 | 8626 |
TP63
AIS B(p51A) B(p51B) EEC3 KET LMS NBP OFC8 RHS SHFM4 TP53CP TP53L TP73L p40 p51 p53CP p63 p73H p73L |
tumor protein p63 | Apigenin results in increased expression of TP63 protein |
increases expression
|
protein |
19397994
|
D047310 | 7161 |
TP73
P73 |
tumor protein p73 | Apigenin results in increased expression of TP73 protein |
increases expression
|
protein |
19397994
|
D047310 | 54658 |
UGT1A1
BILIQTL1 GNT1 HUG-BR1 UDPGT UDPGT_1-1 UGT1 UGT1A |
UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Apigenin results in increased expression of UGT1A1 mRNA] |
increases expression
/ increases reaction |
mRNA |
15090468
|
D047310 | 54658 |
UGT1A1
BILIQTL1 GNT1 HUG-BR1 UDPGT UDPGT_1-1 UGT1 UGT1A |
UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) | Apigenin results in increased expression of UGT1A1 mRNA |
increases expression
|
mRNA |
15090468
|
D047310 | 54658 |
UGT1A1
BILIQTL1 GNT1 HUG-BR1 UDPGT UDPGT_1-1 UGT1 UGT1A |
UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) | [sulforafan co-treated with Apigenin] results in increased expression of UGT1A1 mRNA |
affects cotreatment
/ increases expression |
mRNA |
15090468
|
D047310 | 54658 |
UGT1A1
BILIQTL1 GNT1 HUG-BR1 UDPGT UDPGT_1-1 UGT1 UGT1A |
UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) | UGT1A1 protein results in increased glucuronidation of Apigenin |
increases glucuronidation
|
protein |
14557274
|
D047310 | 54575 |
UGT1A10
UDPGT UGT-1J UGT1-10 UGT1.10 UGT1J |
UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) | UGT1A10 protein results in increased glucuronidation of Apigenin |
increases glucuronidation
|
protein |
14557274
|
D047310 | 54577 |
UGT1A7
UDPGT UDPGT_1-7 UGT-1G UGT1-07 UGT1.7 UGT1G |
UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) | UGT1A7 protein results in increased glucuronidation of Apigenin |
increases glucuronidation
|
protein |
14557274
|
D047310 | 54576 |
UGT1A8
UDPGT UDPGT_1-8 UGT-1H UGT1-08 UGT1.8 UGT1A8S UGT1H |
UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) | UGT1A8 protein results in increased glucuronidation of Apigenin |
increases glucuronidation
|
protein |
14557274
|
D047310 | 54600 |
UGT1A9
HLUGP4 LUGP4 UDPGT UDPGT_1-9 UGT-1I UGT1-09 UGT1-9 UGT1.9 UGT1AI UGT1I |
UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) | UGT1A9 protein results in increased glucuronidation of Apigenin |
increases glucuronidation
|
protein |
14557274
|
D047310 | 7366 |
UGT2B15
HLUG4 UDPGT_2B8 UDPGT2B15 UDPGTH3 UGT2B8 |
UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) | UGT2B15 protein results in increased metabolism of Apigenin |
increases metabolic processing
|
protein |
7835232
|
D047310 | 7402 |
UTRN
DMDL DRP DRP1 |
utrophin | Apigenin results in increased expression of UTRN mRNA |
increases expression
|
mRNA |
22028826
|
D047310 | 7412 |
VCAM1
CD106 INCAM-100 |
vascular cell adhesion molecule 1 | Apigenin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
15113938
|
D047310 | 7412 |
VCAM1
CD106 INCAM-100 |
vascular cell adhesion molecule 1 | Apigenin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
decreases reaction
/ increases expression |
protein |
15113938
|
D047310 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | Apigenin results in decreased expression of VEGFA mRNA |
decreases expression
|
mRNA |
15947208
|
D047310 | 8839 |
WISP2
CCN5 CT58 CTGF-L |
WNT1 inducible signaling pathway protein 2 | Apigenin results in increased expression of WISP2 mRNA |
increases expression
|
mRNA |
23384675
|
D047310 | 8839 |
WISP2
CCN5 CT58 CTGF-L |
WNT1 inducible signaling pathway protein 2 | ESR1 protein inhibits the reaction [Apigenin results in increased expression of WISP2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
23384675
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#615224 | Advanced sleep phase syndrome, familial, 2; fasps2 |
P48730
|
#103780 | Alcohol dependence |
P47869
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#613985 | Beta-thalassemia |
P68871
|
#603902 | Beta-thalassemia, dominant inclusion body type |
P68871
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P31749
P38398 |
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#615279 | Cardiofaciocutaneous syndrome 3; cfc3 |
Q02750
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib |
Q15046
|
#114500 | Colorectal cancer; crc |
P31749
P84022 |
#615109 | Cowden syndrome 6; cws6 |
P31749
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#613916 | Deafness, autosomal recessive 89; dfnb89 |
Q15046
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#609446 | Generalized epilepsy and paroxysmal dyskinesia; gepd |
Q12791
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P37231 |
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#140700 | Heinz body anemias |
P68871
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P00533
P04637 |
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#614104 | Mental retardation, autosomal dominant 7; mrd7 |
Q13627
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P37231
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#176920 | Proteus syndrome |
P31749
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#603903 | Sickle cell anemia |
P68871
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
%612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04637 (related) P68871 (marker) |
H00028 | Choriocarcinoma |
P00533
(related)
P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
|
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) Q15046 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) P68871 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
P35354 (related) |
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00606 | Early infantile epileptic encephalopathy |
P53779
(related)
|
H00228 | Thalassemia |
P68871
(related)
|
H00229 | Sickle cell anemia (SCA) |
P68871
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00523 | Noonan syndrome and related disorders |
Q02750
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H01258 | Generalized epilepsy and paroxysmal dyskinesia (GEPD) |
Q12791
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D000257 | D047310 | Adenoviridae Infections |
therapeutic
|
17149790
|
|
D001943 | D047310 | Breast Neoplasms |
marker/mechanism
therapeutic |
16541309
17132221 22634262 |
|
D003110 | D047310 | Colonic Neoplasms |
therapeutic
|
12842827
|
|
D056486 | D047310 | Drug-Induced Liver Injury |
marker/mechanism
|
22359648
|
|
D009361 | D047310 | Neoplasm Invasiveness |
therapeutic
|
22634262
|
|
D009362 | D047310 | Neoplasm Metastasis |
therapeutic
|
22634262
|
|
D011041 | D047310 | Poisoning |
therapeutic
|
22155090
|
|
D011471 | D047310 | Prostatic Neoplasms |
therapeutic
|
17132221
|